Sonja Nelson

CIK 1674905 · Chief Financial Officer · last filed 2024-03-13

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$10

Companies

3

Total Filings

18

Lifetime Open-Market Net

-$905.9K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MOTS Director 100,709 $0.00 $10 $0 4 2024-03-13
Ambrx Biopharma, Inc. (AMAM) Delisted Chief Financial Officer 0 $28.00 $0 -$125.5K 6 2024-03-07
ImmunityBio, Inc. (NK) Delisted Chief Financial Officer 15,410 -$780.4K 8 2021-01-13

Recent Filings · Page 2 of 2

18 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-01-13 ImmunityBio, Inc. (NK) Delisted Mixed −5,000 -$210.6K EDGAR
2021-01-06 ImmunityBio, Inc. (NK) Delisted Mixed −16,542 -$465.2K EDGAR
2020-08-04 ImmunityBio, Inc. (NK) Delisted Mixed +6,542 -$38.7K EDGAR
2020-03-24 ImmunityBio, Inc. (NK) Delisted Mixed +8,868 -$17.3K EDGAR
2019-08-05 ImmunityBio, Inc. (NK) Delisted Mixed +6,542 -$4.4K EDGAR
2018-08-29 ImmunityBio, Inc. (NK) Delisted Grant (A) $0 EDGAR
2018-08-03 ImmunityBio, Inc. (NK) Delisted Grant (A) $0 EDGAR
2018-03-26 ImmunityBio, Inc. (NK) Delisted Exer (M) +15,000 $0 EDGAR
Showing 1118 of 18
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.